{"filings":[{"id":96831,"accession_number":"0001493152-26-021282","cik":1938569,"company_name":"Palomino Laboratories Inc.","ticker":"PALX","form_type":"8-K","filed_at":"2026-05-05T23:59:59+00:00","items":["3.02","9.01"],"status":"ready","headline":"Palomino Labs completes $1.88M second closing of private placement; total proceeds $16.98M","event_type":"other_material","confidence":"high","bullets":["Second closing on Apr 30, 2026: 470,000 shares at $4.00/share, gross proceeds $1,880,000.","Combined with initial closing (3,773,853 shares at $4.00), total shares 4,243,853 and aggregate proceeds $16,975,412.","Laidlaw & Company received cash fees (10% of introduced proceeds, 5% of company-introduced) and expense reimbursement.","Placement agent also received 374,761 warrants at $4.80 exercise price (120% of offering price), 5-year term, cash exercise.","Offering exempt under Section 4(a)(2) and Rule 506 of the Securities Act to accredited investors."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96830,"accession_number":"0001493152-26-018963","cik":1938569,"company_name":"Palomino Laboratories Inc.","ticker":"PALX","form_type":"8-K","filed_at":"2026-04-24T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Palomino Labs raises $15.1M in private placement; additional closings up to $30M","event_type":"other_material","confidence":"high","bullets":["Sold 3,773,853 shares at $4.00/share in initial closing, raising $15.1M.","Additional closings up to $30M total may occur until April 30, 2026.","Laidlaw & Company acts as placement agent, earning 10%/5% fees and warrants.","Enters registration rights agreements to file resale registration statement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96829,"accession_number":"0001493152-26-015767","cik":1938569,"company_name":"Palomino Laboratories Inc.","ticker":"PALX","form_type":"8-K","filed_at":"2026-04-09T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Palomino Laboratories moves principal executive offices from New York to Goleta, CA","event_type":"other","confidence":"high","bullets":["New address: 130 Castilian Drive, Suite 102, Goleta, CA 93117.","Old address: 12 E. 49th Street, 11th Floor, New York, NY 10017.","Change effective April 8, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127728,"accession_number":"0001493152-25-020229","cik":1938569,"company_name":"Palomino Laboratories Inc.","ticker":"PALX","form_type":"8-K","filed_at":"2025-10-30T23:59:59+00:00","items":["3.02","9.01"],"status":"ready","headline":"Palomino Labs adds $275K to private placement; total raised ~$9.76M","event_type":"other_material","confidence":"high","bullets":["On Oct 24, 2025, Palomino sold 183,334 units at $1.50/unit for $275,001 gross proceeds.","Each unit consists of one share of common stock and one warrant (exercise price $1.50, term 1 yr after trading start).","Placement agent Laidlaw & Co. received 10% cash commission, 2% expense allowance, and 18,333 warrants at $1.80 (7-yr term).","Combined with prior Oct 6 closing, total units sold: 6,504,017 for aggregate gross proceeds of ~$9.76 million."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127727,"accession_number":"0001493152-25-016939","cik":1938569,"company_name":"Palomino Laboratories Inc.","ticker":"PALX","form_type":"8-K","filed_at":"2025-10-06T23:59:59+00:00","items":["2.01","3.02","1.01","3.03","5.01","5.02","5.03","5.05","5.06","9.01"],"status":"ready","headline":"Palomino Laboratories goes public via reverse merger with Unite Acquisition, raises $9.5M in PIPE","event_type":"m_and_a","confidence":"high","bullets":["Merger closed Sep 29, 2025; Palomino (pre-revenue microLED optical transceiver) becomes public; total shares outstanding 18.6M.","PIPE raised $9.48M at $1.50/Unit (6.32M Units); SAFEs converted into 1.54M Units at $1.20 for $1.85M.","New officers: CEO Jeff Shealy, CAO Jason Tu, Secretary Richard Ogawa; board: Shealy, Ogawa, Steven DenBaars.","Three-year lock-up for Palomino stockholders; company intends to seek OTCQB or exchange listing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":1.0,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}